Cargando…

Recurrence and mortality following treatment for Clostridum difficile infection with metronidazole or vancomycin

Detalles Bibliográficos
Autores principales:	Stevens, V, Nelson, R, Khader, K, Jones, M, Brown, K, Samore, M, Rubin, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474898/ http://dx.doi.org/10.1186/2047-2994-4-S1-O38

Ejemplares similares

Economic analysis of veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections
por: Nelson, RE, et al.
Publicado: (2015)

The determinants of C. difficile infection in long-term care facilities: a portrait of patient- and facility-level factors across 90 care regions in the veterans affairs health care system
por: Brown, KA, et al.
Publicado: (2015)

US costs and outcomes associated with Clostridium difficile infections: a systematic literature review, meta-analysis, and mathematical model
por: Schweizer, ML, et al.
Publicado: (2015)

O033: Is MRSA inpatient transmission driving high MRSA hospital importation in the US veterans affairs?
por: Jones, M, et al.
Publicado: (2013)

Efficacy of Oral Vancomycin, Oral Metronidazole, or IV Metronidazole Prophylaxis at Reducing the Risk of Clostridium difficile Recurrence
por: O’Connell, Matthew, et al.
Publicado: (2017)

The Impact of Clostridum Difficile on Surgical Rate Among Ulcerative Colitis Patients: A Systemic Review and Meta-analysis
por: Peng, Jiang-Chen, et al.
Publicado: (2015)

Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin
por: Maaß, Sandra, et al.
Publicado: (2018)

Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin
por: Tannous, George, et al.
Publicado: (2010)

Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination
por: Erikstrup, Lise Tornvig, et al.
Publicado: (2015)

Initial Oral Vancomycin vs. Oral Vancomycin After Metronidazole for Severe Clostridium difficile Infection
por: Shah, Sunish, et al.
Publicado: (2017)

Cost analysis of an active surveillance strategy for Clostridium difficile using an agent-based simulation
por: Rubin, M, et al.
Publicado: (2015)

489. Validation of the SHEA/IDSA Severity Criteria to Predict Poor Outcomes Among Inpatients and Outpatients With Clostridium difficile Infection
por: Stevens, Vanessa, et al.
Publicado: (2018)

1630 Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multi-State Model
por: Stevens, Vanessa, et al.
Publicado: (2014)

Which is the Preferred Regimen for Non-Severe Clostridioides difficile Infection in Korea, Vancomycin or Metronidazole?
por: Kim, Jieun, et al.
Publicado: (2022)

Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole
por: Abujamel, Turki, et al.
Publicado: (2013)

A6 MECHANISMS UNDERLYING GUT DYSFUNCTION FOLLOWING C. DIFFICILE INFECTION AND IMPLICATIONS FOR TREATMENT
por: Saqib, Z, et al.
Publicado: (2022)

1593. Recurrence of Clostridium difficile Infection in Multiple Myeloma Patients Receiving Prophylactic Oral Vancomycin or Oral Metronidazole vs. No Prophylaxis
por: Moran, Gisele, et al.
Publicado: (2018)

Vancomycin-specific T Cell responses in allergic and non-allergic individuals
por: Polak, Marta E, et al.
Publicado: (2014)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection
por: Zhang, Kevin, et al.
Publicado: (2021)

A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity
por: Di, Xiuzhen, et al.
Publicado: (2015)

Comparative Effectiveness of Vancomycin vs. Metronidazole in Mild Clostridium difficile Infections, and Potential Impact on Subsequent Vancomycin-Resistant Enterococcus (VRE) Isolation
por: Youngster, Ilan, et al.
Publicado: (2017)

488. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridium difficile Infection in Critically Ill Patients
por: Vega, Ana, et al.
Publicado: (2018)

2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients
por: Vega, Ana D, et al.
Publicado: (2019)

Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection
por: Whitney, Laura, et al.
Publicado: (2023)

Clostridium difficile infection in medical wards – a mathematical model
por: Schechner, V, et al.
Publicado: (2015)

Prevalence of asymptomatic Clostridium difficile colonization in tertiary hospital patients in Australia
por: Kanamori, L Furuya, et al.
Publicado: (2015)

Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections
por: Yin, Jianyi, et al.
Publicado: (2019)

Vancomycin vs metronidazole use for the treatment of Clostridioides difficile infection in a tertiary care hospital in Saudi Arabia
por: Alhameed, Abrar F., et al.
Publicado: (2023)

Plasmid-mediated metronidazole resistance in Clostridioides difficile
por: Boekhoud, Ilse M., et al.
Publicado: (2020)

Corrigendum to: Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections
por: Yin, Jianyi, et al.
Publicado: (2020)

The experience of the National Institute for Infectious Diseases "Prof. Dr. Matei Balş" in bacterial resettlement therapy trough fecal microbiota transplant in recurrent infections with C. difficile
por: Apostolescu, Cătălin, et al.
Publicado: (2014)

Clostridium difficile colitis – a serious current problem
por: Dumitru, Irina Magdalena, et al.
Publicado: (2013)

O081: Reduction of clostridium difficile infections with enhanced evidence-based practices and antimicrobial stewardship
por: Alexander-Mills, K, et al.
Publicado: (2013)

Epidemiological and clinical considerations on Clostridium difficile colitis in Braşov County
por: Cocuz, Maria Elena, et al.
Publicado: (2014)

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
por: Figueroa, Iris, et al.
Publicado: (2012)

Clinical utility of the GeneXpert assay for the diagnosis of Clostridium difficile infections
por: Florea, Dragoş, et al.
Publicado: (2014)

O030 Reduction in fall risk markers following CPAP treatment of obstructive sleep apnoea in people over 65 years
por: Stevens, D, et al.
Publicado: (2022)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

A12 STEPWISE COORDINATION OF COLONIC NEUTROPHILS AND INNATE LYMPHOID CELLS IN THE ONSET AND RESOLUTION OF CLOSTRIDIOIDES DIFFICILE TOXIN-INDUCED INJURY
por: Flannigan, K L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9g651p7j3nv2gm71dkjr7hnnal